Drug Information

Drug General Information
Drug ID
D0E8YH
Former ID
DIB000088
Drug Name
NCX 1022
Indication Atopic dermatitis [ICD9: 691.8, 692.9; ICD10:L00-L99] Phase 2 [551443]
Company
NicOx SA
Target and Pathway
Target(s) Cyclooxygenase Target Info Modulator [527171]
References
Ref 551443Clinical pipeline report, company report or official report of NicOx SA.
Ref 527171Anti-inflammatory effects of nitric oxide-releasing hydrocortisone NCX 1022, in a murine model of contact dermatitis. Br J Pharmacol. 2004 Nov;143(5):618-25. Epub 2004 Aug 16.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.